SWK Holdings Corporation (SWKH)

US — Financial Services Sector
Peers: FGBI  FVCB  LRFC  MNSB  SAMG  SPFI  VKI  VKQ  VPV  VTN 

Automate Your Wheel Strategy on SWKH

With Tiblio's Option Bot, you can configure your own wheel strategy including SWKH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol SWKH
  • Rev/Share 3.3494
  • Book/Share 23.9324
  • PB 0.6272
  • Debt/Equity 0.1079
  • CurrentRatio 11.302
  • ROIC 0.045

 

  • MktCap 184166696.0
  • FreeCF/Share 3.19
  • PFCF 4.7209
  • PE 10.0447
  • Debt/Assets 0.0953
  • DivYield 0.2665
  • ROE 0.0637

 

  • Rating A
  • Score 4
  • Recommendation Buy
  • P/E Score 3
  • DCF Score 5
  • P/B Score 4
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

SWK Holdings Corporation (SWKH) Q1 2025 Earnings Call Transcript
SWKH
Published: May 16, 2025 by: Seeking Alpha
Sentiment: Neutral

SWK Holdings Corporation (NASDAQ:SWKH ) Q1 2025 Earnings Conference Call May 16, 2025 10:00 AM ET Company Participants Susan Xu - Investor Relations Jody Staggs - President and Chief Executive Officer Adam Rice - Chief Financial Officer Conference Call Participants Stefano Latapy - Cannell Capital Operator Good day, everyone. Welcome to the SWK Holdings First Quarter 2025 Conference Call.

Read More
image for news SWK Holdings Corporation (SWKH) Q1 2025 Earnings Call Transcript
SWK Holdings Announces First Quarter 2025 Earnings Release Date and Conference Call
SWKH
Published: May 09, 2025 by: Accesswire
Sentiment: Neutral

DALLAS, TX / ACCESS Newswire / May 9, 2025 / SWK Holdings Corporation (Nasdaq:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that it will issue its first quarter 2025 earnings results after the market close on Thursday, May 15, 2025. The Company will host a conference call to discuss its corporate and financial results on Friday, May 16, 2025 at 10:00am ET.

Read More
image for news SWK Holdings Announces First Quarter 2025 Earnings Release Date and Conference Call
SWK Holdings Corporation (SWKH) Q4 2024 Earnings Call Transcript
SWKH
Published: March 20, 2025 by: Seeking Alpha
Sentiment: Neutral

SWK Holdings Corporation (NASDAQ:SWKH ) Q4 2024 Earnings Conference Call March 20, 2025 10:00 AM ET Company Participants Susan Xu - IR Jody Staggs - President & CEO Adam Rice - CFO Conference Call Participants Operator Greetings. Welcome to the SWK Holdings Fourth Quarter 2024 Conference Call.

Read More
image for news SWK Holdings Corporation (SWKH) Q4 2024 Earnings Call Transcript
SWK Holdings Announces Monetization of Royalty Portfolio
SWKH
Published: March 19, 2025 by: Accesswire
Sentiment: Neutral

DALLAS, TX / ACCESS Newswire / March 19, 2025 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced the monetization of its royalty portfolio through two transactions. On March 17, 2025, ANI Pharmaceuticals, Inc. exercised its buyout option related to the Iluvien royalty, which resulted in a payment of approximately $17.3 million to SWK.

Read More
image for news SWK Holdings Announces Monetization of Royalty Portfolio
SWK Holdings Corporation Announces Financial Results for Fourth Quarter 2024
SWKH
Published: March 19, 2025 by: Accesswire
Sentiment: Neutral

Conference Call Scheduled for Thursday, March 20, 2025, at 09:00 a.m. CST Corporate Highlights Fourth quarter 2024 GAAP net income was $5.9 million, compared with GAAP net income of $2.8 million for the fourth quarter 2023.

Read More
image for news SWK Holdings Corporation Announces Financial Results for Fourth Quarter 2024

About SWK Holdings Corporation (SWKH)

  • IPO Date 1999-09-23
  • Website https://www.swkhold.com
  • Industry Asset Management
  • CEO Jody. D Staggs
  • Employees 24

SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.